Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): Single institution experience

Journal of Neuro-Oncology

Volumn 82, Issue 3, 2007, Pages 273-279

  Silvani, A ^a   Salmaggi, A ^a   Eoli, M ^a   Lamperti, E ^a   Broggi, G ^a   Marras, C E ^a   Fariselli, L ^a   Milanesi, I ^a   Fiumani, A ^a   Gaviani, P ^a   Erbetta, A ^a   Giovagnoli, A R ^a   Pollo, B ^a   Botturi, A ^a   Boiardi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Chemotherapy; HD Ara C; Methotrexate; Primary Central Nervous System Lymphoma

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; FOLINIC ACID; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN RADIATION; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; FEMALE; HUMAN; LEUKOPENIA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RADIATION DOSE; SALVAGE THERAPY; SEPSIS; SIDE EFFECT; TESTIS DISEASE; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; MIDDLE AGED; RADIOTHERAPY; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 34247268186     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9276-0     Document Type: Article

References (32)

1. DeAngelis LM, Wendy Seiferheld WS, Clifford Schold SC, Barbara Fisher B, Schultz CJ (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation therapy oncology group study 93-10. J Clin Oncol 20:4643-4648
2. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150
3. Ferreri AJ, Reni M, Pasini F, Calderoni A, Tirelli U, Pivnik A, Aondio GM, Ferrarese F, Gomez H, Ponzoni M, Borisch B, Berger F, Chassagne C, Iuzzolino P, Carbone A, Weis J, Pedrinis E, Motta T, Jouvet A, Barbui T, Cavalli F, Blay JY (2002) A multicenter study of treatment of primary CNS lymphoma. Neurology 58:1513-1520
4. Harder H, Holtel H, Bromberg JE, Poortmans P, Haaxma-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544-547
5. Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:548-555
6. Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U (2005) Neuropsychological outcome after chemotherapy for primary CNS lymphoma: A prospective study. Neurology 64:1184-1188
7. Common Toxicity Criteria Cancer Therapy Evaluation Program. Common Toxicity Criteria, Version 2.0. DCTD, NCI, NIH, DHHS. March (1998)
8. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J (1998) Age-specific norms for the Mini-Mental State Exam. Neurology 38:1565-1568
9. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280
10. Abrey LE, DeAngelis LM, Yahalom J (1998) Long term survival in primary CNS lymphoma. J Clin Oncol 16:859-863
11. Neuwelt EA, Guastadisegni PE, Varallyay P, Doolittle ND (2005) Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery. AJNR Am J Neuroradiol 26:258-265
12. Batchelor TT, Kolak G, Ciordia R, Foster CS, Henson JW (2003) High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711-715
13. Hoang-Xuan K, Taillandier L, Chinot O, Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N, Delattre JY, Baron B (2003) European organization for research and treatment of cancer brain tumor group: chemotherapy alone as initial treatment for primary CNS Lymphoma in patients older than 60 years: A multicenter phase II study (26952) of the European organization for research and treatment of cancer brain tumor group. J Clin Oncol 21:2726-2731
14. Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489-4495
15. Korfel A, Martus P, Nowrousian R et al (2003) The multicenter BMPD study for primary CNS lymphoma: Long term results. Onkologie 26:37 (abstr 353)
16. O'Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, Olver I, Trotter G (2000) Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 18:519-526
17. Glass J, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81:188-195
18. Reni M, Ferreri AJ, Guha-Thakurta N, Blay JY, Dell'Oro S, Biron P, Hochberg FH (2001) Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphoma treated with upfront high-dose methotrexate (>1 g/m2 HD-MTX). Int J Radiat Oncol Biol Phys 51:418-424
19. Bessell EM, Graus F, Lopez-Guillermo A, Villa S, Verger E, Petit J, Holland I, Byrne P (2001) Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 20:231-236
20. Reni M, Ferreri AJ (2004) Is withdrawal of consolidation radiotherapy an evidence-based strategy in primary central nervous system lymphomas? J Clin Oncol 22:1165-1167
21. De Vita VT (1983) The relationship between tumor mass and resistance to treatment of cancer. Cancer 51:1209-1220
22. Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FD, Batchelor TT, Loeffler JS (2005) Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS Lymphoma. J Clin Oncol 23:1507-1513
23. Boiardi A, Silvani A, Pozzi A, Salmaggi A (1998) Radiotherapy at tumor recurrence in primary CNS lymphoma. Neurology 50:1934-1935
24. Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A (1999) Chemotherapy is effective as early treatment for primary central nervous system lymphoma. J Neurol 246:31-37
25. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150
26. DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10:635-643
27. Baumann MA, Ritch PS, Hande KR, Williams GA, Topping TM, Anderson T (1986) Treatment of intraocular lymphoma with high-doseAra-C. Cancer 57:1273-1275
28. Strauchen JA, Dalton J, Friedman AH (1989) Chemotherapy in the management of intraocular lymphoma. Cancer 63:1918-1921
29. Abrey LE, Tracy T. Batchelor TT, Ferreri AJM, Gospodarowicz M, Pulczynski EJ, Zucca E, Justine R. Smith JR, Korfel A, Soussain C, DeAngelis LM, Neuwelt EA, O'Neill BP, Thiel E, Shenkier T, Graus F, van den Bent M, Seymour JF, Poortmans P, Armitage JO, Franco Cavalli F (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS Lymphoma. J Clin Oncol 23:5034-5043
30. Fine HA (2002) Primary central nervous system lymphoma: Time to ask the question. J Clin Oncol 20:4615-4617
31. Mead GM, Bleehen NM, Gregor A, Bullimore J, Shirley D, Rampling RP, Trevor J, Glaser MG, Lantos P, Ironside JW, Moss TH, Brada M, Whaley JB, Stenning SP (2000) A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 89:1359-1370
32. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK,Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) European organisation for research and treatment of cancer brain tumor andradiotherapy groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 52:987-996